Goodmedicinestartswithgoodgovernance

Clinical governance is the framework that ensures healthcare organisations deliver safe, effective, and accountable care. In a traditional GP clinic, governance happens partly by proximity - doctors work alongside colleagues, practice managers observe workflows, and patients interact face-to-face with their care team. Telehealth removes that proximity, which means governance has to be more deliberate, more structured, and more transparent.

At InstantMed, patients submit health information through structured intake forms rather than describing symptoms in a consulting room. A doctor reviews that information asynchronously - there is no physical examination, no visual cues from body language, and no opportunity to ask follow-up questions in real time. This makes the quality of the intake process, the clinical decision-making framework, and the audit trail significantly more important than they might be in a face-to-face setting.

Our governance framework exists to answer a straightforward question: how do we ensure that every clinical decision made on this platform is consistent, documented, and inside scope? The answer involves structured protocols, audit trails, defined boundaries, and continuous improvement - none of which are optional, and all of which are documented here.

Every clinical decision at InstantMed is traceable. When a doctor approves, declines, or escalates a patient request, that decision is recorded with the clinical reasoning, the information reviewed, and the outcome. This audit trail is not optional - it is built into the platform architecture and cannot be bypassed.

Our Medical Director conducts structured audits of clinical decisions across all service types. This includes random sampling of approved certificates and prescriptions, targeted review of declined or escalated cases, and thematic analysis of decision patterns over time. The goal is ensuring consistency, identifying protocol gaps, and catching systemic issues before they affect patients.

We maintain a structured incident reporting framework. Any adverse outcome, clinical near-miss, patient complaint, or process failure is logged, investigated, and reviewed. Post-incident reviews result in documented process changes where warranted. This is standard practice in hospital settings and accredited general practices - we apply the same rigour to telehealth.

Patient feedback is integrated into our quality cycle. Every interaction generates an opportunity for the patient to report concerns, and those reports feed directly into clinical review processes. A complaint about a declined request is treated differently from a complaint about communication - both are investigated, but through different pathways with different clinical oversight.

InstantMed maintains strict prescribing boundaries that go beyond minimum regulatory requirements. We do not prescribe Schedule 8 (controlled) substances under any circumstances. This is a hard boundary enforced at the platform level - our intake system will not accept requests for these medications, and the restriction cannot be clinician-overridden. There is no clinical scenario in which an asynchronous telehealth consultation is the appropriate channel for initiating or continuing controlled substance therapy.

We focus on repeat prescriptions for medications that the patient is already established on, prescribed by their regular GP or specialist. We do not initiate new medications for complex conditions, adjust doses for medications with narrow therapeutic indices, or prescribe medications that require monitoring through blood tests or other investigations that we cannot facilitate remotely.

Every prescription request is validated against our clinical protocols before it reaches a doctor. The system checks for known contraindications, flags medications that require specific monitoring, and identifies requests that fall outside our defined scope of practice. The reviewing doctor makes the final clinical decision - the system supports that decision with structured information, but does not replace clinical judgement.

If a prescribing request falls outside our scope, we decline it with a clear explanation and a recommendation that the patient consult their regular GP or an appropriate specialist. Declining a request is not a failure of service - it is the governance framework working as designed. A platform that approves everything is not practising medicine; it is dispensing.

Patient safety in telehealth depends on knowing what you can and cannot assess remotely. Our intake forms are designed to identify red-flag symptoms - clinical indicators that suggest the patient needs in-person assessment rather than telehealth management. Chest pain, sudden neurological symptoms, signs of serious infection, and other emergency presentations are flagged automatically, and the patient is directed to call 000 or attend their nearest emergency department.

When a doctor reviews a request and identifies concerns that do not require emergency care but do require further assessment, they decline the request with specific guidance. This might include recommending the patient see their regular GP for examination, attend a pathology service for blood tests, or consult a specialist. The doctor documents their reasoning, and the patient receives a clear explanation - not a generic rejection.

Our escalation pathways are tiered. Emergency presentations are redirected immediately with clear instructions. Non-emergency clinical concerns result in a declined request with documented reasoning and a recommendation for alternative care. Complex cases that fall within our scope but require additional oversight are escalated to our Medical Director for review before a decision is communicated to the patient.

We track escalation and decline rates as quality indicators. An unusually low decline rate would be as much cause for concern as an unusually high one - it could suggest that clinical boundaries are not being applied consistently. These metrics are reviewed quarterly by our Medical Director as part of the continuous improvement cycle.

InstantMed operates within the regulatory framework established by several Australian bodies. The Australian Health Practitioner Regulation Agency (AHPRA) registers and regulates all health practitioners in Australia - every doctor on our platform holds current, unrestricted AHPRA registration, which can be independently verified on the public register. AHPRA's codes of conduct and guidelines for technology-based consultations inform our clinical protocols directly.

The Therapeutic Goods Administration (TGA) regulates the prescription and supply of therapeutic goods in Australia. Our prescribing protocols comply with TGA scheduling requirements, and our scope exclusions (particularly around Schedule 8 substances) reflect both TGA regulations and our own clinical risk assessment. The Pharmaceutical Benefits Scheme (PBS) guidelines inform our approach to repeat prescriptions, ensuring that subsidised medications are prescribed in accordance with PBS requirements.

Our clinical governance is built around Australian medical regulation, privacy law, prescribing rules, documented scope boundaries, and the realities of asynchronous telehealth. We do not claim third-party college accreditation unless it has been formally granted.

Patient privacy is governed by the Australian Privacy Principles (APPs) under the Privacy Act 1988. We collect only the health information necessary to provide the requested service, store it with field-level encryption, and do not share it with third parties except where required for clinical care or by law. Our privacy practices are documented in our Privacy Policy, and patients can request access to their health information at any time. The Fair Work Act 2009 is also relevant to our medical certificate service - certificates issued through InstantMed comply with the evidentiary requirements for workplace absence documentation.